Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset

Cited by (259)

Items 201–259 of 259

1. Asymptomatic ST segment elevation.
   Ross MacKenzie · 2004 · PubMed
2. Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography
   Beatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, Harald Stefanits, Cécile Philippe, Maria Weber, Thomas Czech, Marie‐Claude Menet, Xavier Declèves, Johannes Andreas Hainfellner et al. · 2019 · EJNMMI Research
3. Molecular determinants of neuroprotection in blood-brain interfaces of the cynomolgus monkey
   N. Strazielle, Sandrine Blondel, Joachim Confais, R. El Khoury, H. Contamin, J. Ghersi-Egea · 2025 · Frontiers in Pharmacology
4. Exploring efficient and effective mammalian models for Alzheimer’s disease
   Mitsunori Kayano · 2025 · Frontiers in Aging Neuroscience
5. Challenges and opportunities in the use of transcriptomic characterization of human iPSC-derived BBB models
   Sara Wellens, Fabien Gosselet, Maxime Culot · 2022 · Toxicology in Vitro
6. Investigating CNS distribution of PF‐05212377, a P‐glycoprotein substrate, by translation of 5‐HT6 receptor occupancy from non‐human primates to humans
   Aarti Sawant‐Basak, Laigao M. Chen, PETER A. LOCKWOOD, Tracey L. Boyden, Angela C. Doran, Jessica Y. Mancuso, Kenneth R. Zasadny, Timothy J. McCarthy, Evan D. Morris, Richard E. Carson et al. · 2023 · Biopharmaceutics & Drug Disposition
7. Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction
   Emőke Sóskuti, Nóra Szilvásy, Csilla Temesszentandrási‐Ambrus, Zoltán Urbán, Olivér Csíkvári, Zoltán Szabó, Gábor Kecskeméti, Éva Pusztai, Zsuzsanna Gáborik · 2024 · Pharmaceutics
8. Molecular cloning and tissue distribution of a novel marmoset ABC transporter
   Shotaro Uehara, Yasuhiro Uno, Takashi Inoue, Erika Sasaki, Hiroshi Yamazaki · 2017 · Biopharmaceutics & Drug Disposition
9. Intravenous infusion of rocuronium bromide prolongs emergence from propofol anesthesia in rats
   Kaoru Suzuki, Hiroshi Sunaga, Kentaro Yamakawa, Yoshifumi Suga, Ichiro Kondo, Tsunehisa Tsubokawa, Shoichi Uezono · 2021 · PLoS ONE
10. Established and emerging new approach methodologies in neuroscience
    Dorien Imberechts, Annelii Ny, Daniëlle Copmans · 2025 · Frontiers in Neuroscience
11. Intracerebral Distribution of Drugs with Diverse Blood–brain Barrier Transport Characteristics: In vivo Analysis using Brain Microdialysis in Cynomolgus Monkeys
    Takuya Fujita, Yukari Kamikozawa, Makoto Ozawa, Yoriko Tajima, Toshiki Kurosawa, Yuki Katagiri, Hiroko Kawaguchi, Akito Kakuuchi, Rei Miyamoto, Kentaro Wakayama et al. · 2025 · Pharmaceutical Research
12. The ATP-Binding Cassette Transporter-Mediated Efflux Transport of Ganciclovir at the Blood–Brain Barrier
    Yuheng Shan, Yuying Cen, Xiaojiao Xu, Ping Li, Jing Chen, Zhiyong Nie, Jiatang Zhang · 2024 · European Journal of Drug Metabolism and Pharmacokinetics
13. In Vitro 2D and 3D Cell Models of the Human Blood-Brain Barrier: Demonstrating the Beneficial Influence of Shear Stress on Brain Microvascular Endothelial Cell Phenotype
    Keith D. Rochfort, Philip M. Cummins · 2025 · Neuromethods
14. Identification of AAV variants with improved transduction of human vascular endothelial cells by screening AAV capsid libraries in non-human primates
    Maria Stamataki, Julia Lüschow, Christina Schlumbohm, Malik Alawi, Lars Peter Lunding, Eberhard Fuchs, Martin Trepel, Markus Schwaninger, Jakob Körbelin · 2025 · Gene Therapy
15. Studying Molecular Aspects of the Blood-Brain Barrier Using an in Vitro Model: Contribution of a Global Proteomics Strategy
    Yannis Karamanos · 2014 · Journal of Biosciences and Medicines
16. Targeting the blood-brain barrier with solid and vesicular nanoparticles decorated with ligands of solute carriers
    Mária Mészáros · 2019
17. Application of genetically modified rodent models in drug discovery and development for translation of clinical ADME properties
    Robert S. Jones, Justin Q. Ly, Jae Hoon Chang · 2020 · Elsevier eBooks
18. Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs
    Pablo Torres‐Vergara, Robin Rivera, Carlos Escudero, Jeffrey I. Penny · 2023 · Advances in experimental medicine and biology
19. Targeted and Untargeted Proteomics-based Comparison of Adenoviral Infected hCMEC/D3 and hBMEC as a Human Brain Endothelial Cells to Study the OATP2B1 Transporter
    Valerio Taggi, A. M. Schäfer, Jonny Kinzi, Danilo Ritz, I. Seibert, Stefan Oswald, H. M. Z. zu Schwabedissen · 2025 · Molecular Neurobiology
20. Ex Vivo Plasma Application on Human Brain Microvascular Endothelial-like Cells for Blood–Brain Barrier Modeling
    Sophie-Charlotte Nelz, Elisabeth Lück, Anne Schölzel, Martin Sauer, Jacqueline Heskamp, Sandra Doß · 2025 · International Journal of Molecular Sciences
21. Construction and Functional Evaluation of 2D and 3D Human Blood–Brain Barrier Models
    Toshiki Kurosawa, Yoshiyuki Kubo, Yoshiharu Deguchi · 2025 · Current human cell research and applications
22. Systematic evaluation of BBB-penetrant AAV capsids in marmosets identifies VCAP-102 as a highly efficient brain-transducing capsid
    Yasunori Matsuzaki, Ayumu Konno, Kenji Sakamoto, Yasuo Uchida, Tetsuya Terasaki, Hirokazu Hirai · 2026 · Molecular Therapy Advances
23. Design and delivery of targeting chimeras therapeutics in managing central nervous system disorders
    Shuo Liu, Wei Xu, Mengxi Wang, Zhen Mao, Jianping Zhou, Xiaochen Gu, Guochen Han, Yang Ding · 2026 · Targetome
24. The liver-brain axis, from its function to preventive therapeutic strategies in diseases
    Yuehua Chen, Shangcheng Xu, Tao Sun · 2026 · Frontiers in Endocrinology
25. Quantitative and Targeted Proteomics of the Blood-Brain Barrier: Species and Cell Line Differences
    Shingo Ito, Takeshi Masuda, Sumio Ohtsuki · 2022 · AAPS advances in the pharmaceutical sciences series
26. Pregnenolone Sulfate Permeation at the Blood–Brain Barrier is Independent of OATP2B1—In Vivo and In Vitro Insights
    Valerio Taggi, Anima M. Schäfer, Stefan Oswald, Jonny Kinzi, Isabell Seibert, Alaa Al‐Khatib, Henriette E. Meyer zu Schwabedissen · 2025 · Biopharmaceutics & Drug Disposition
27. In Vitro Models of CNS Barriers
    N. Joan Abbott, Siti Rafidah Yusof, Andreas Reichel, Diana E. M. Dolman, Jane Elizabeth Preston · 2022 · AAPS advances in the pharmaceutical sciences series
28. Quantitative Aspects of Nanodelivery Across the Blood-Brain Barrier : Exemplified with the Opioid Peptide DAMGO
    Annika Lindqvist · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
29. Endothelial iron homeostasis regulates BBB integrity via the HIF2α – Ve-cadherin pathway
    Daniel Rand, Orly Ravid, Dana Atrakchi, Hila Israelov, Yael Bresler, Chen Shemesh, Liora Omesi, Sigal Liraz Zaltsman, Fabien Gosselet, Taber S. Maskrey et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
30. A Human Brain-Chip for modelling brain pathologies and screening of BBB crossing therapeutic strategies
    Shek Man Chim, Kristen Howell, Alexandros G. Kokkosis, Brian Zambrowicz, Katia P. Karalis, Elias Pavlopoulos · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
31. Quantitative targeted absolute proteomics (QTAP)-based rational research on the human blood-brain barrier transport
    Masanori Tachikawa, Yasuo Uchida, Tetsuya Terasaki · 2013 · Drug Delivery System
32. IS THE MELTZER-LYON TECHNIC FOR THE DIAGNOSIS AND TREATMENT OF GALL BLADDER DISEASE AN ASSET OR A LIABILITY?
    Walter C. Alvarez · 1922 · PubMed
33. Tracking effects of oxytocin crossing the blood brain barrier in vivo and in vitro
    Trisha Chakraborty · 2024 · Library, Museums and Press - UDSpace (University of Delaware)
34. Regulation of ABCB1 expression and activity in porcine brain endothelial cells
    Pablo Vergara · 2016 · Research Explorer (The University of Manchester)
35. Methodological developments in small animal PET neuroimaging
    Miklós Tóth · 2015 · Figshare
36. Development of Novel Methodology and Its Application for Clarifying the Transport Function of the Blood-brain Barrier
    Tetsuya Terasaki · 2021 · YAKUGAKU ZASSHI
37. 日記と物語の関係をめぐって : 『更級日記』を中心に
    守幸 伊藤 · 1992 · Institutional Repositories DataBase (IRDB)
38. Effect of intravenous infusion of rocuronium on emergence from propofol anesthesia in rats
    Kaoru Suzuki, Hiroshi Sunaga, Kentaro Yamakawa, Yoshifumi Suga, Ichiro Kondo, Tsunehisa Tsubokawa, Shoichi Uezono · 2020
39. Special issue on applications of in vitro, in vivo, and modeling and simulation tools for central nervous system drug disposition
    Li Di · 2022 · Biopharmaceutics & Drug Disposition
40. Does nonlinear blood-brain barrier transport matter for morphine dosing strategies?
    Berfin Gülave, Divakar Budda, Mohammed A. A. Saleh, J. G. Coen van Hasselt, Elizabeth C. M. de Lange · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
41. Analysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
    J. Chaves · 2024 · Queensland University of Technology
42. VCAP-102 Achieves Exceptional BBB Penetration in Marmosets After Ten Years of AAV Capsid Evaluation
    Yasunori Matsuzaki, Ayumu Konno, Yasuo Uchida, Tetsuya Terasaki, Hirokazu Hirai · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
43. Additional file 2 of Mouse embryonic stem cell-derived blood–brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis
    Anna Jezierski, Jez Huang, Arsalan S. Haqqani, Julie Haukenfrers, Liu, Ziying, Ewa Baumann, Caroline Sodja, Claudie Charlebois, Christie E. Delaney, Alexandra T. Star et al. · 2024 · Figshare
44. Additional file 1 of Claudin-5a is essential for the functional formation of both zebrafish blood-brain barrier and blood-cerebrospinal fluid barrier
    Li, Yanyu, Wang, Chunchun, Liang Zhang, Chen, Bing, Yuqian Mo, Jingjing Zhang · 2022 · Figshare
45. Additional file 1 of Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
    Stéphanie Chasseigneaux, Véronique Cochois, Lucas Lecorgne, Murielle Lochus, Sophie Nicolic, Corinne Blugeon, Laurent Jourdren, David Gomez‐Zepeda, Tenzer, Stefan, Sylvia Sanquer et al. · 2024 · Figshare
46. Additional file 4 of Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
    Stéphanie Chasseigneaux, Véronique Cochois, Lucas Lecorgne, Murielle Lochus, Sophie Nicolic, Corinne Blugeon, Laurent Jourdren, David Gomez‐Zepeda, Tenzer, Stefan, Sylvia Sanquer et al. · 2024 · Figshare
47. Additional file 6 of Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
    Stéphanie Chasseigneaux, Véronique Cochois, Lucas Lecorgne, Murielle Lochus, Sophie Nicolic, Corinne Blugeon, Laurent Jourdren, David Gomez‐Zepeda, Tenzer, Stefan, Sylvia Sanquer et al. · 2024 · Figshare
48. Additional file 3 of Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
    Stéphanie Chasseigneaux, Véronique Cochois, Lucas Lecorgne, Murielle Lochus, Sophie Nicolic, Corinne Blugeon, Laurent Jourdren, David Gomez‐Zepeda, Tenzer, Stefan, Sylvia Sanquer et al. · 2024 · Figshare
49. Additional file 5 of Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
    Stéphanie Chasseigneaux, Véronique Cochois, Lucas Lecorgne, Murielle Lochus, Sophie Nicolic, Corinne Blugeon, Laurent Jourdren, David Gomez‐Zepeda, Tenzer, Stefan, Sylvia Sanquer et al. · 2024 · Figshare
50. Additional file 1 of Mouse embryonic stem cell-derived blood–brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis
    Anna Jezierski, Jez Huang, Arsalan S. Haqqani, Julie Haukenfrers, Liu, Ziying, Ewa Baumann, Caroline Sodja, Claudie Charlebois, Christie E. Delaney, Alexandra T. Star et al. · 2024 · Figshare
51. Additional file 2 of Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation
    Stéphanie Chasseigneaux, Véronique Cochois, Lucas Lecorgne, Murielle Lochus, Sophie Nicolic, Corinne Blugeon, Laurent Jourdren, David Gomez‐Zepeda, Tenzer, Stefan, Sylvia Sanquer et al. · 2024 · Figshare
52. Gabapentin CNS exposure and analgesic response are modulated by OCT2 genotype in patients with chronic neuropathic pain
    Lina Zhou, Priscila Akemi Yamamoto, Melody Walker, A. Costa, Gabriela Rocha Lauretti, Fabíola Dach, Stephan Schmidt, Natalia Valadares de Moraes · 2026 · Frontiers in Pharmacology
53. NMDA receptor of the blood brain barrier : mechanism of action and interaction with tPA
    Anupriya Mehra · 2017
54. LC-MS/MS based analysis of membrane transporters in the blood-brain barrier : interest in neuropsychopharmacology
    David Gomez‐Zepeda · 2016
55. Miniaturization and automation of a well-established human in vitro blood-brain barrier model, and the use of these models to evaluate nanoparticles mechanisms of transport
    Elisa L. J. Moya · 2021 · theses.fr (ABES)
56. The OCTN2 transporter can be targeted by carnitine functionalised non-ionic surfactant vesicles to deliver drugs across the blood-brain barrier
    Thomas David Bateman-Price, Jane Elizabeth Preston, Gary Burgess, Kerrie E Hargrave, Logan Mackie, Holly van Dessel, Wendy Butcher, Margaret Gill Hartley, Andrew Herbert, Courtney Cohen et al. · 2026 · Biomedicine & Pharmacotherapy
57. Antibody-Based Biologics for CNS Disorders
    Eric Ka‐Wai Hui, Rubén J. Boado · 2026 · Antibodies
58. Bioinspired Nanomaterials for Parkinson's Disease: Engineering Membrane Interfaces to Overcome the Blood–Brain Barrier and Enable Neuron-Targeted Delivery
    Qucheng Huang, Yuanyuan Zuo, Yining Xie, Zhenye Liu, Leiyi Wang, Hewei Xu, Miao Yu, Chang Liu · 2026 · ACS Biomaterials Science & Engineering
59. Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors
    Tammy Ladduwahetty, Benjamin F. Rahemtulla, Eric P. A. Talbot, Joseph Bateman, Neil Benson, 陈鹏源, Xiaoling F. Cockcroft, Li Feng, Elnaz Gozalpour, Kui Lin et al. · 2026 · Journal of Medicinal Chemistry